• vaccine

    Safety of a prospective vaccine for COVID-19 comes “first and foremost”, the World Health Organization’s chief scientist said on Wednesday, as a trial of a candidate from AstraZeneca was paused, at least temporarily, due to concerns over side effects. “Just because we talk about speed…it doesn’t mean we start compromising or cutting corners on what ...
  • Remdesivir

    The Trump administration has urged US states to get ready to distribute a potential COVID-19 vaccine by November 1 — two days before the presidential election. Dallas-based wholesaler McKesson Corp. has a deal with the federal government and will be requesting permits to set up distribution centers when a vaccine becomes available. “The normal time ...
  • 312

    Moderna Inc said on Wednesday it has started talks with several countries for supply agreements for its experimental coronavirus vaccine and has received about $400 million in deposits for potential supply. Last week, Moderna announced the start of a late-stage trial on 30,000 people to demonstrate that its vaccine is safe and effective, the final ...
  • leaders

      Australia’s national science agency said on Thursday it has commenced the first stage of testing potential vaccines for COVID-19, as it joins a global race to halt the coronavirus pandemic. Pre-clinical testing by the Commonwealth Scientific and Industrial Research Organisation (CSIRO), comprising injecting ferrets with two potential vaccines, was underway at its high-containment biosecurity ...